Cresco Labs (CRLBF) Return on Capital Employed (2021 - 2026)
Cresco Labs (CRLBF) reported Return on Capital Employed of 2.76% for Q1 2026, down 1012.0% on a YoY basis from 0.3% in Q1 2025, and down 12.46% quarter-over-quarter from 2.46% in Q4 2025.
Cresco Labs (CRLBF) Return on Capital Employed (2021 - 2026) Analysis & Trends
Cresco Labs has reported Return on Capital Employed for 6 years, with the latest figure at 2.76% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 1012.0% year-over-year to 2.76%; the trailing twelve-month figure through Mar 2026 stood at 2.76% (down 1012.0% YoY), and the FY2025 full-year result was 2.38%, down 1088.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 2.76%, down from 2.46% in the prior quarter.
- The five-year high for Return on Capital Employed was 9.49% in Q3 2024, with the low at 21.64% in Q3 2023.
- Historically, Return on Capital Employed has averaged 3.05% across 5 years, with a median of 2.76% in 2026.
- Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 2676 bps — and 2024, when it jumped 3112 bps.
- Cresco Labs' Return on Capital Employed stood at 5.96% in 2022, then decreased by 25 bps to 7.45% in 2023, then soared by 213 bps to 8.42% in 2024, then plunged by 129 bps to 2.46% in 2025, then fell by 12 bps to 2.76% in 2026.
- The last three Return on Capital Employed figures came in at 2.76% (Q1 2026), 2.46% (Q4 2025), and 5.5% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Cresco Labs | - | - | 75.45 Mn | -2.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.76% |
| Dec 31, 2025 | -2.46% |
| Sep 30, 2025 | 5.50% |
| Jun 30, 2025 | 6.02% |
| Mar 31, 2025 | 7.36% |
| Dec 31, 2024 | 8.42% |
| Sep 30, 2024 | 9.49% |
| Jun 30, 2024 | -1.56% |
| Mar 31, 2024 | -5.41% |
| Dec 31, 2023 | -7.45% |
| Sep 30, 2023 | -21.64% |
| Jun 30, 2023 | -10.39% |
| Mar 31, 2023 | -7.80% |
| Dec 31, 2022 | -5.96% |
| Sep 30, 2022 | 5.13% |
| Jun 30, 2022 | -13.57% |
| Mar 31, 2022 | -14.70% |
| Dec 31, 2021 | -15.67% |
| Mar 31, 2021 | 1.97% |